596 related articles for article (PubMed ID: 3274453)
41. Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation.
Osakabe T; Uchida H; Masaki Y; Yokota K; Sato K; Nakayama Y; Ohkubo M; Kumano K; Endo T; Watanabe K
Transplant Proc; 1989 Feb; 21(1 Pt 2):1598-600. PubMed ID: 2652520
[No Abstract] [Full Text] [Related]
42. Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance.
Taube D; Welsh KI; Bewick M; Dische FE; Palmer A; Parsons V; Snowden S
Transplant Proc; 1987 Feb; 19(1 Pt 3):1961-3. PubMed ID: 3274456
[No Abstract] [Full Text] [Related]
43. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
[No Abstract] [Full Text] [Related]
44. Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody.
Friend PJ; Rebello P; Oliveira D; Manna V; Cobbold SP; Hale G; Jamieson NV; Jamieson I; Calne RY; Harris DT
Transplant Proc; 1995 Feb; 27(1):869-70. PubMed ID: 7879212
[No Abstract] [Full Text] [Related]
45. Effective induction immunosuppression for cadaver renal transplantation at the St. Francis Regional Medical Center.
Shield CF
Clin Transpl; 1990; ():265-74. PubMed ID: 2129408
[TBL] [Abstract][Full Text] [Related]
46. Triple therapy improves the survival of cadaver renal allografts affected by acute tubular necrosis.
Bakran A; Johnson RW; Dyer PA; Mallick NP; Gokal R
Transplant Proc; 1989 Feb; 21(1 Pt 2):1278-9. PubMed ID: 2652423
[No Abstract] [Full Text] [Related]
47. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
Cole E; Robinson C; Bear R
Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
[No Abstract] [Full Text] [Related]
48. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
[No Abstract] [Full Text] [Related]
49. Management of immunosuppressive problems in renal allograft recipients.
Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
Transplant Proc; 1987 Feb; 19(1 Pt 3):1951-4. PubMed ID: 3547899
[No Abstract] [Full Text] [Related]
50. Cadaveric renal transplantation with cyclosporine monotherapy.
Aikawa A; Sells RA; Bakran A; Tewari A
Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
[No Abstract] [Full Text] [Related]
51. Plasma exchange vs cyclosporine retrieval therapy in steroid-resistant acute rejection of renal allografts.
Dikshit MP; Acharya VN; Trivedi HS; Almeida AF
Transplant Proc; 1992 Oct; 24(5):1724. PubMed ID: 1412811
[No Abstract] [Full Text] [Related]
52. Cadaver renal transplantation without maintenance steroids.
Johnson RW; Mallick NP; Bakran A; Pearson RC; Scott PD; Dyer P; Donaghue D; Morris D; Gokal R
Transplant Proc; 1989 Feb; 21(1 Pt 2):1581-2. PubMed ID: 2652513
[No Abstract] [Full Text] [Related]
53. Live donor renal transplantation with low-dose triple immunosuppression.
Francis DM; Millar RJ; Walker RG; Nicholls K; Powell H; Jones C; Kockelbergh R; Becker G
Transplant Proc; 1992 Oct; 24(5):2243. PubMed ID: 1413041
[No Abstract] [Full Text] [Related]
54. Alternate-day cyclosporine A and azathioprine in experimental dog renal allografts.
Collier DS; Calne RY; De Curtins M; Thiru S; White DJ; Jamieson NV; Thick M; Barroso E
Transplant Proc; 1987 Feb; 19(1 Pt 2):1279-80. PubMed ID: 3274318
[No Abstract] [Full Text] [Related]
55. Monitoring the response to anti-rejection therapy with serum neopterin.
Smillie AE; Rigby RJ; Petrie JJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):1869-70. PubMed ID: 2652608
[No Abstract] [Full Text] [Related]
56. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function.
Henny FC; Kootte AM; van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050
[No Abstract] [Full Text] [Related]
57. Influence of total lymphoid irradiation plus cyclosporine on kidney graft outcome in high-risk patients.
Cortesini R; Berloco P; Famulari A; Trovati A; Iappelli M; Renna Molajoni E; Bachetoni A; Pretagostini R; Marinucci G; Capua A
Transplant Proc; 1987 Feb; 19(1 Pt 3):1949-50. PubMed ID: 3079063
[No Abstract] [Full Text] [Related]
58. Transfer of cytomegalovirus infection via renal allografts: role of immunosuppressive regimens on the transfer rate, and effect of cytomegalovirus infections on renal allograft rejection; study in a rat model.
Bruning JH; Bruggeman CA; van Breda Vriesman PJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):2089-90. PubMed ID: 2540562
[No Abstract] [Full Text] [Related]
59. The course of chronic, progressive renal allograft dysfunction during cyclosporine therapy is modified by addition of azathioprine.
Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Turcotte JG; Campbell DA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1529-31. PubMed ID: 2652493
[No Abstract] [Full Text] [Related]
60. Prognosis of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisolone.
Chu SH; Lai MK; Huang CC; Chuang CK; Chen HW; Chen CS
Transplant Proc; 1994 Aug; 26(4):1981-2. PubMed ID: 8066641
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]